BK
72
-2
NWS
79
-4
GLW
48
-5
EMC
53
-3
GPC
40
2
WFC
80
-2
IFF
53
2
PLD
56
8
SWKS
33
-10
ROK
67
5
RCL
88
-2
CI
52
-7
MAT
38
-3
ETR
68
-3
ADM
24
2
REGN
42
-2
PFG
50
-2
SLG
62
-4
AAPL
45
3
LOW
58
2
BK
72
-2
NWS
79
-4
GLW
48
-5
EMC
53
-3
GPC
40
2
WFC
80
-2
IFF
53
2
PLD
56
8
SWKS
33
-10
ROK
67
5
RCL
88
-2
CI
52
-7
MAT
38
-3
ETR
68
-3
ADM
24
2
REGN
42
-2
PFG
50
-2
SLG
62
-4
AAPL
45
3
LOW
58
2
Financhill
Back

MetLife Vs. Neurogene Industry Stock Comparison

Buy
66

MET
MetLife

Last Price:
82.96
Seasonality Move:
2.89%
Sell
5

NGNE
Neurogene

Last Price:
40.09
Seasonality Move:
50.43%
Buy
66
MetLife (MET) is a Buy

Is MetLife a Buy, Sell or Hold?

  • The current MetLife [MET] share price is $82.02. The Score for MET is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • MET is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
5
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

MET Stock Price Chart

What is MetLife's stock price today?

  • The MetLife share price today is $82.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MET is experiencing selling pressure, which indicates risk of future bearish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $39.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

MET Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 51.07 Buy
Chaikin Money Flow: -1963922 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (80.45 - 85.19) Sell
Bollinger Bands (100): (71.96 - 82.08) Buy

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.3 Buy
Relative Strength Index (14 RSI): 39.1 Sell
Chaikin Money Flow: -346626 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.29 - 61.53) Sell
Bollinger Bands (100): (34.11 - 50.51) Sell

MET Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 81 Buy
20-day SMA: 82.25 Sell
50-day SMA: 81.13 Buy
200-day SMA: 73.93 Buy
8-day EMA: 81.52 Buy
20-day EMA: 81.75 Buy
50-day EMA: 80.61 Buy
200-day EMA: 74.57 Buy

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 60.39 Sell
20-day SMA: 53.17 Sell
50-day SMA: 46.66 Sell
200-day SMA: 38.93 Buy
8-day EMA: 54.03 Sell
20-day EMA: 53.18 Sell
50-day EMA: 48.36 Sell
200-day EMA: 38.47 Buy

MetLife Earnings Growth & MET Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.00 per share, and an increase next year of $1.39 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

MetLife Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):